![]() |
市场调查报告书
商品编码
1844352
手术机器人市场机会、成长动力、产业趋势分析及2025-2034年预测Surgical Robots Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球手术机器人市场价值为 81 亿美元,预计到 2034 年将以 17.2% 的复合年增长率增长至 384 亿美元。

这一增长的驱动力源于微创手术需求的不断增长、慢性病发病率的上升、机器人技术的持续进步以及医疗保健支出的增加。医院和外科中心正在增加对机器人系统的投入,以提高手术精准度、缩短患者康復时间并最大程度地减少手术併发症。手术机器人融合了机械手臂、先进影像技术和即时资料整合技术,为复杂手术提供了更佳的控制力、灵活性和可视性。人工智慧、触觉回馈和精细成像工具等技术进步正在进一步提升外科医生的手术能力,同时减轻疲劳。经济高效的机器人模型(尤其是占地面积更小、配置更灵活的机器人模型)的出现,正在扩大大型医院和小型外科中心的机器人应用范围。此外,机器人即服务 (RaaS) 和租赁等新型商业模式正在消除高昂的前期资本壁垒,从而促进机器人手术的更广泛应用。这种转变正在提升机器人手术在不同地区和医疗机构的普及率,确保市场长期成长势头,并在全球范围内实现手术机器人系统的更广泛部署。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 81亿美元 |
| 预测值 | 384亿美元 |
| 复合年增长率 | 17.2% |
2024年,器械及配件市场占68%的市占率。这一主导地位源自于机器人辅助手术中频繁且重复使用的手术器械及配件。与一次性购买的主流机器人系统不同,这些组件在达到一定使用次数后即可更换,为製造商创造了经常性收入来源。这种对耗材的持续需求确保了持续的销售成长,并支持了市场的可持续性。持续的产品升级和器械设计的创新也巩固了该市场的强势地位,因为医疗保健提供者正在寻求最新的工具来提高手术精度和手术效果。
预计到2034年,妇科手术市场将以17%的复合年增长率成长。子宫内膜异位症、子宫肌瘤和生殖系统癌症等妇科疾病病例的增加,增加了对外科手术的需求。机器人辅助手术因其能够减少术后併发症、缩短恢復时间并提高手术精准度,正成为该领域的首选方法。这些优势在生育相关手术中尤其重要,因为精准度和生殖功能的保留至关重要。
2024年,美国手术机器人市场规模达45亿美元,预计复合年增长率达15.9%。美国完善的医疗基础设施,加上高技术应用率,使得机器人手术在医院和门诊中心广泛使用。在美国,肥胖、心血管疾病和各种癌症等生活方式疾病的发生率不断上升,刺激了对外科手术的需求。医疗服务提供者持续采用机器人平台来提高手术精度、简化工作流程并满足日益增长的患者期望,从而确保北美市场稳定成长。
影响手术机器人产业竞争格局的关键参与者包括 INTUITIVE、meerecompany、CMR SURGICAL、ACCURAY、Stryker、CASCINATION、Medtronic、Smith & Nephew、ELMED MEDICAL SYSTEMS、THINK SURGICAL、GLOBUSRENDICAL、ZIMMER BIOMET、DistGIalmotion、RENAISHAPEN MEDICAL、ZIMMER BIOMET、DistGI。这些公司正透过持续创新和全球扩张策略推动市场向前发展。手术机器人市场的领先製造商正透过策略创新、地理扩张和灵活的商业模式来加强其市场影响力。重点仍然是透过人工智慧功能、即时分析和改进的人体工学来增强机器人系统,以优化手术结果并减少临床医生的疲劳。各公司也推出了适用于小型手术室的模组化和紧凑型系统,使其产品更容易被中型和地区医院使用。
The Global Surgical Robots Market was valued at USD 8.1 billion in 2024 and is estimated to grow at a CAGR of 17.2% to reach USD 38.4 billion by 2034.

The growth is driven by the increasing demand for minimally invasive procedures, a rise in chronic disease incidence, continuous advancements in robotic technology, and greater healthcare spending. Hospitals and surgical centers are increasingly investing in robotic systems to improve surgical precision, reduce patient recovery time, and minimize procedural complications. Surgical robots, which combine robotic arms, advanced imaging, and real-time data integration, offer enhanced control, flexibility, and visibility for complex surgeries. Technological advancements such as artificial intelligence, haptic feedback, and refined imaging tools are further enhancing surgeon capabilities while decreasing fatigue. The emergence of cost-effective robotic models, particularly those with smaller footprints and flexible configurations, is expanding access in both large hospitals and smaller surgical centers. Additionally, new business models like Robotics-as-a-Service (RaaS) and leasing are enabling broader adoption by eliminating high upfront capital barriers. This shift is increasing the availability of robotic surgery across different regions and healthcare settings, ensuring long-term market momentum and broader deployment of surgical robotic systems globally.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $8.1 Billion |
| Forecast Value | $38.4 Billion |
| CAGR | 17.2% |
The instruments and accessories segment held 68% share in 2024. This dominance stems from the frequent and recurring use of surgical instruments and accessories in every robotic-assisted procedure. These components, unlike the main robotic systems that represent one-time purchases, require replacement after a set number of uses, creating a recurring revenue stream for manufacturers. This ongoing demand for consumables ensures consistent sales growth and supports market sustainability. Continuous product upgrades and innovation in instrument design also contribute to the segment's strong position, as healthcare providers seek the latest tools for enhanced precision and procedural outcomes.
The gynecology surgery segment is anticipated to grow at a CAGR of 17% through 2034. Rising cases of gynecologic conditions such as endometriosis, fibroids, and reproductive system cancers are increasing the need for surgical interventions. Robotic-assisted surgeries are becoming the preferred approach in this specialty due to their ability to offer reduced postoperative complications, faster recovery times, and greater surgical accuracy. These benefits are particularly important in fertility-related procedures, where precision and preservation of reproductive function are critical.
U.S. Surgical Robots Market was valued at USD 4.5 billion in 2024 and is expected to grow at a CAGR of 15.9%. The country's well-established healthcare infrastructure, combined with a high rate of technological adoption, has led to widespread integration of robotic surgery across hospitals and ambulatory centers. In the U.S., increasing incidences of lifestyle diseases such as obesity, cardiovascular disorders, and various cancers are fueling demand for surgical interventions. Healthcare providers continue to embrace robotic platforms to improve surgical precision, streamline workflows, and meet rising patient expectations, ensuring steady market growth across North America.
Key players influencing the competitive landscape of the Surgical Robots Industry include INTUITIVE, meerecompany, CMR SURGICAL, ACCURAY, Stryker, CASCINATION, Medtronic, Smith & Nephew, ELMED MEDICAL SYSTEMS, THINK SURGICAL, GLOBUS MEDICAL, ZIMMER BIOMET, Distalmotion, RENISHAW, and ASENSUS SURGICAL. These companies are driving the market forward through continued innovation and global expansion strategies. Leading manufacturers in the surgical robots market are strengthening their market presence through strategic innovation, geographic expansion, and flexible business models. A key focus remains on enhancing robotic systems with AI capabilities, real-time analytics, and improved ergonomics to optimize surgical outcomes and reduce clinician fatigue. Companies are also introducing modular and compact systems suitable for smaller operating rooms, making their products more accessible to medium-sized and regional hospitals.